degree from harvard medical school in 1947 he interned at the hospital of the university of pennsylvania from 1948 to 1952 he was a post doctoral fellow in the department of physiological chemistry at the university of pennsylvania school of medicine and fellow in clinical medicine in the department of medicine in collaboration with samuel gurin at the university of pennsylvania brady discovered the enzyme system for the biosynthesis of long chain fatty acids and later discovered the role of malonate coenzyme a in this process after two and one half years on active duty in the u s naval medical corps he joined the national institutes of health in 1954 he was chief of the developmental and metabolic neurology branch in the national institute of neurological disorders and stroke from 1972 to 2006 dr brady and his colleagues identified the enzymatic defects in gaucher s disease niemann pick disease fabry disease and the specific metabolic abnormality in tay sachs disease he and his associates developed diagnostic carrier detection prenatal tests for these conditions and effective enzyme replacement therapy for patients with gaucher disease and fabry disease these were the first ever enzyme replacement therapy ert treatments for lysosomal diseases